{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:40:53Z","timestamp":1792456853639,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1038\/s41429-019-0241-5","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T05:49:33Z","timestamp":1570168173000},"page":"877-889","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Liposidomycin, the first reported nucleoside antibiotic inhibitor of peptidoglycan biosynthesis translocase I: The discovery of liposidomycin and related compounds with a perspective on their application to new antibiotics"],"prefix":"10.1038","volume":"72","author":[{"given":"Ken-ichi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"key":"241_CR1","unstructured":"Global tuberculosis report 2018, World Health Organization, ISBN 978-92-4-156564-6."},{"key":"241_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.addr.2016.04.026","volume":"102","author":"DT Hoagland","year":"2016","unstructured":"Hoagland DT, Liu J, Lee RB, Lee RE. New agents for the treatment of drug-resistant Mycobacterium tuberculosis. Adv Drug Deliv Rev. 2016;102:55\u201372.","journal-title":"Adv Drug Deliv Rev."},{"key":"241_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ja.2017.126","volume":"71","author":"M Igarashi","year":"2018","unstructured":"Igarashi M, Ishizaki Y, Takahashi Y. New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development. J Antibiot. 2018;71:15\u201325.","journal-title":"J Antibiot"},{"key":"241_CR4","first-page":"131","volume":"18","author":"S Suzuki","year":"1965","unstructured":"Suzuki S, et al. A new antibiotic polyoxin A. J Antibiot. 1965;18:131.","journal-title":"J Antibiot."},{"key":"241_CR5","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.7164\/antibiotics.41.1711","volume":"41","author":"K Isono","year":"1988","unstructured":"Isono K. Nucleoside antibiotics: streuture, biological activity, and biosynthesis. J Antibiot. 1988;41:1711\u201339.","journal-title":"J Antibiot"},{"key":"241_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0163-7258(91)90028-K","volume":"52","author":"K Isono","year":"1991","unstructured":"Isono K. Current progress on nucleoside antibiotics. Phramacol Ther. 1991;52:269\u201386.","journal-title":"Phramacol Ther."},{"key":"241_CR7","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.7164\/antibiotics.38.1617","volume":"38","author":"K Isono","year":"1985","unstructured":"Isono K, et al. Liposidomycins: novel nucleoside antibiotics which inhibit bacterial peptidoglycan synthesis. J Antibiot. 1985;38:1617\u201321.","journal-title":"J Antibiot."},{"key":"241_CR8","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.1021\/ja00221a052","volume":"110","author":"M Ubukata","year":"1988","unstructured":"Ubukata M, Isono K, Kimura K, Nelson CC, McCloskey JA. The structure of liposidomycin B, an inhibitor of bacterial peptidoglycan synthesis. J Am Chem Soc. 1988;110:4416\u20137.","journal-title":"J Am Chem Soc."},{"key":"241_CR9","first-page":"1811","volume":"53","author":"K Kimura","year":"1989","unstructured":"Kimura K, et al. Liposidomycin C inhibits phospho-N-acetylmuramyl-pentapeptide transferase in peptidoglycan synthesis of Escherichia coli Y-10. Agric Biol Chem. 1989;53:1811\u20135.","journal-title":"Agric Biol Chem."},{"key":"241_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1039\/b202149h","volume":"20","author":"K Kimura","year":"2003","unstructured":"Kimura K, Bugg TDH. Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis. Nat Prod Rep. 2003;20:252\u201373.","journal-title":"Nat Prod Rep"},{"key":"241_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1039\/B816215H","volume":"27","author":"M Winn","year":"2010","unstructured":"Winn M, Goss RJM, Kimura K, Bugg TDH. Antimicrobial nucleoside antibiotics targetting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis. Nat Prod Rep. 2010;27:279\u2013304.","journal-title":"Nat Prod Rep"},{"key":"241_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.7164\/antibiotics.56.580","volume":"56","author":"M Igarashi","year":"2003","unstructured":"Igarashi M, et al. Caprazamycin B, a novel anti-tuberculosis antibiotic, from Streptomyces sp. J Antibiot. 2003;56:580\u20133.","journal-title":"J Antibiot"},{"key":"241_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ja.2013.9","volume":"66","author":"Y Takahashi","year":"2013","unstructured":"Takahashi Y, et al. Novel semisynthetic antibiotics from caprazamycins A-G: caprazene derivatives and their antibacterial activity. J Antibiot. 2013;66:171\u20138.","journal-title":"J Antibiot."},{"key":"241_CR14","first-page":"226","volume":"10","author":"A Fleming","year":"1929","unstructured":"Fleming A. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenz\u00e6. Br J Exp Pathol. 1929;10:226\u201336.","journal-title":"Br J Exp Pathol."},{"key":"241_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.tibtech.2010.12.006","volume":"29","author":"TD Bugg","year":"2011","unstructured":"Bugg TD, Braddick D, Dowson CG, Roper DI. Bacterial cell wall assembly: still an attractive antibacterial target. Trends Biotechnol 2011;29:167\u201373.","journal-title":"Trends Biotechnol"},{"key":"241_CR16","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1128\/jb.177.14.4194-4197.1995","volume":"177","author":"ED Brown","year":"1995","unstructured":"Brown ED, Vivas EI, Walsh CT, Kolter R. MurA (MurZ), the enzyme that catalyzes the first committed step in peptidoglycan biosynthesis, is essential in Escherichia coli. J Bacteriol. 1995;177:4194\u20137.","journal-title":"J Bacteriol."},{"key":"241_CR17","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/pro.5560030718","volume":"3","author":"TE Benson","year":"1994","unstructured":"Benson TE, Walsh CT, Hogle JM. Crystallization and preliminary X-ray crystallographic studies of UDP-N-acetylenolpyruvylglucosamine reductase. Protein Sci. 1994;3:1125\u20137.","journal-title":"Protein Sci."},{"key":"241_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1126\/science.166.3901.122","volume":"166","author":"D Hendlin","year":"1969","unstructured":"Hendlin D, et al. Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science. 1969;166:122\u20133.","journal-title":"Science."},{"key":"241_CR19","first-page":"204","volume":"5","author":"RL Harned","year":"1955","unstructured":"Harned RL, Hidyph PH, Labaw EK. Cycloserine. I. A preliminary report. Antibiot Chemother. 1955;5:204\u20135.","journal-title":"Antibiot Chemother."},{"key":"241_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3109\/14756366.2015.1050010","volume":"31","author":"MA Azam","year":"2016","unstructured":"Azam MA, Jayaram U. Inhibitors of alanine racemase enzyme: a review. J Enzym Inhib Med Chem. 2016;31:517\u201326.","journal-title":"J Enzym Inhib Med Chem."},{"key":"241_CR21","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1128\/jb.173.3.1021-1026.1991","volume":"173","author":"M Ikeda","year":"1991","unstructured":"Ikeda M, Wachi M, Jung HK, Ishino F, Matsuhashi M. The Escherichia coli mraY gene encoding UDP-N-acetylmuramoyl-pentapeptide: undecaprenyl-phosphate phospho-N-acetylmuramoyl-pentapeptide transferase. J Bacteriol. 1991;173:1021\u20136.","journal-title":"J Bacteriol."},{"key":"241_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.7164\/antibiotics.24.215","volume":"24","author":"A Takatsuki","year":"1971","unstructured":"Takatsuki A, Arima K, Tamura G. Tunicamycin, a new antibiotic. I. Isolation and characterization of tunicamycin. J Antibiot. 1971;24:215\u201323.","journal-title":"J Antibiot."},{"key":"241_CR23","unstructured":"Aoyagi A, Murakami A. New antibiotic A-84830A. published unexamined Japanese patent application, JP2005-247725."},{"key":"241_CR24","unstructured":"Fujita Y, Kizuka M, Murakami A. Novel A-97065 substances, their fermentative manufacture, and use as pharmaceuticals. published unexamined Japanese patent application, JP 2006-252237."},{"key":"241_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/ja.2008.71","volume":"61","author":"R Murakami","year":"2008","unstructured":"Murakami R, et al. A-94964, a novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. I. Taxonomy, isolation and biological activity. J Antibiot. 2008;61:537\u201344.","journal-title":"J Antibiot."},{"key":"241_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ja.2011.38","volume":"64","author":"Y Fujita","year":"2011","unstructured":"Fujita Y, et al. A-90289 A and B, new inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 60405. J Antibiot. 2011;64:495\u2013501.","journal-title":"J Antibiot."},{"key":"241_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1039\/C2MD20245J","volume":"4","author":"Xl Chi","year":"2013","unstructured":"Chi Xl, et al. The muraminomicin biosynthetic gene cluster and enzymatic formation of the 2-deoxyaminoribosyl appendage. Medchemcomm. 2013;4:239\u201343.","journal-title":"Medchemcomm."},{"key":"241_CR28","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.7164\/antibiotics.39.1047","volume":"39","author":"H Yamaguchi","year":"1986","unstructured":"Yamaguchi H, et al. Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization. J Antibiot. 1986;39:1047\u201353.","journal-title":"J Antibiot."},{"key":"241_CR29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.7164\/antibiotics.42.662","volume":"42","author":"M Inukai","year":"1989","unstructured":"Inukai M, et al. Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. I. Taxonomy, fermentation, isolation and physico-chemical properties. J Antibiot. 1989;42:662\u20136.","journal-title":"J Antibiot."},{"key":"241_CR30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.7164\/antibiotics.42.506","volume":"42","author":"JP Karwowski","year":"1989","unstructured":"Karwowski JP, et al. Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. I. Taxonomy of the producing organism and fermentation. J Antibiot. 1989;42:506\u201311.","journal-title":"J Antibiot."},{"key":"241_CR31","doi-asserted-by":"publisher","first-page":"595","DOI":"10.7164\/antibiotics.47.595","volume":"47","author":"S Chatterjee","year":"1994","unstructured":"Chatterjee S, et al. Napsamycins, new Pseudomonas active antibiotics of the mureidomycin family from Streptomyces sp. HIL Y-82,11372. J Antibiot. 1994;47:595\u20138.","journal-title":"J Antibiot"},{"key":"241_CR32","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/S0960-894X(02)00469-9","volume":"12","author":"YI Lin","year":"2002","unstructured":"Lin YI, et al. Muraymycins, novel peptidoglycan biosynthesis inhibitors: semisynthesis and SAR of their derivatives. Bioorg Med Chem Lett. 2002;12:2341\u20134.","journal-title":"Bioorg Med Chem Lett"},{"key":"241_CR33","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/ja.2007.88","volume":"60","author":"R Murakami","year":"2007","unstructured":"Murakami R, et al. A-102395, a new inhibitor of bacterial translocase I, produced by Amycolatopsis sp. SANK 60206 . J Antibiot. 2007;60:690\u20135.","journal-title":"J Antibiot"},{"key":"241_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ja.2007.16","volume":"60","author":"Y Xie","year":"2007","unstructured":"Xie Y, Chen R, Si S, Sun C, Xu H. A new nucleosidyl-peptide antibiotic, sansanmycin. J Antibiot. 2007;60:158\u201361.","journal-title":"J Antibiot."},{"key":"241_CR35","first-page":"1239","volume":"3","author":"B Heinemann","year":"1953","unstructured":"Heinemann B, Kaplan MA, Muir RD, Hooper IR. Amphomycin, a new antibiotic. Antibiot Chemother. 1953;3:1239\u201342.","journal-title":"Antibiot Chemother."},{"key":"241_CR36","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/0006-291X(79)91797-2","volume":"86","author":"H Tanaka","year":"1979","unstructured":"Tanaka H, Oiwa R, Matsukura S, Omura S. Amphomycin inhibits phospho-N-acetylmuramyl-pentapeptide translocase in peptidoglycan synthesis of Bacillus. Biochem Biophys Res Commun. 1979;86:902\u20138.","journal-title":"Biochem Biophys Res Commun."},{"key":"241_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.7164\/antibiotics.21.126","volume":"21","author":"E Higashide","year":"1968","unstructured":"Higashide E, Hatano K, Shibata M, Nakazawa K. Enduracidin, a new antibiotic. I. Streptomyces fungicidicus No. B5477, an enduracidin producing organism. J Antibiot. 1968;21:126\u201337.","journal-title":"J Antibiot."},{"key":"241_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.7164\/antibiotics.37.309","volume":"37","author":"B Cavalleri","year":"1984","unstructured":"Cavalleri B, Pagani H, Volpe G, Selva E, Parenti F. A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics. J Antibiot. 1984;37:309\u201317.","journal-title":"J Antibiot"},{"key":"241_CR39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1126\/science.1254522","volume":"345","author":"LT Sham","year":"2014","unstructured":"Sham LT, et al. Bacterial cell wall. MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis. Science. 2014;345:220\u20132.","journal-title":"Science."},{"key":"241_CR40","first-page":"606","volume":"3","author":"MH Mccormick","year":"1955","unstructured":"Mccormick MH, Mcguire JM, Pittenger GE, Pittenger RC, Stark WM. Vancomycin, a new antibiotic. I. Chemical and biologic properties. Antibiot Annu. 1955;3:606\u201311. 1956","journal-title":"Antibiot Annu."},{"key":"241_CR41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1126\/science.102.2650.376","volume":"102","author":"BA Johnson","year":"1945","unstructured":"Johnson BA, Anker H, Meleney FL. Bacitracin: a new antibiotic produced by a member of the B. subtilis group. Science. 1945;102:376\u20137.","journal-title":"Science."},{"key":"241_CR42","doi-asserted-by":"publisher","first-page":"a021113","DOI":"10.1101\/cshperspect.a021113","volume":"5","author":"LJ Alderwick","year":"2015","unstructured":"Alderwick LJ, Harrison J, Lloyd GS, Birch HL. The mycobacterial cell wall-peptidoglycan and arabinogalactan. Cold Spring Harb Perspect Med. 2015;5:a021113.","journal-title":"Cold Spring Harb Perspect Med."},{"key":"241_CR43","doi-asserted-by":"publisher","first-page":"e01310","DOI":"10.1128\/AAC.01310-17","volume":"61","author":"S Husz\u00e1r","year":"2017","unstructured":"Husz\u00e1r S, et al. N-Acetylglucosamine-1-phosphate transferase, WecA, as a validated drug target in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2017;61:e01310\u201317.","journal-title":"Antimicrob Agents Chemother."},{"key":"241_CR44","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1128\/AAC.35.2.234","volume":"35","author":"F Isono","year":"1991","unstructured":"Isono F, Inukai M. Mureidomycin A, a new inhibitor of bacterial peptidoglycan synthesis. Antimicrob Agents Chemother. 1991;35:234\u20136.","journal-title":"Antimicrob Agents Chemother."},{"key":"241_CR45","first-page":"301","volume":"24","author":"E Cabib","year":"1993","unstructured":"Cabib E, Mol PC, Shaw JA, Choi WJ. Biosynthesis of cell wall and septum during yeast growth. Arch Med Res. 1993;24:301\u20133.","journal-title":"Arch Med Res."},{"key":"241_CR46","first-page":"222","volume":"13","author":"PM Chaudhary","year":"2013","unstructured":"Chaudhary PM, Tupe SG, Deshpande MV. Chitin synthase inhibitors as antifungal agents. Mini Rev Med Chem. 2013;13:222\u201336.","journal-title":"Mini Rev Med Chem."},{"key":"241_CR47","volume-title":"Tunicamycin","author":"G Tamura","year":"1982","unstructured":"Tamura G. Tunicamycin. Tokyo: Japan Scientific Press; 1982."},{"key":"241_CR48","doi-asserted-by":"crossref","first-page":"e00211","DOI":"10.1002\/prp2.211","volume":"4","author":"F Foufelle","year":"2007","unstructured":"Foufelle F, Fromenty B. Role of endoplasmic reticulum stress in drug-induced toxicity. Pharmacol Res Perspect. 2007;4:e00211.","journal-title":"Pharmacol Res Perspect"},{"key":"241_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nchembio.2270","volume":"13","author":"JK Hakulinen","year":"2017","unstructured":"Hakulinen JK, et al. MraY-antibiotic complex reveals details of tunicamycin mode of action. Nat Chem Biol. 2017;13:265\u20137.","journal-title":"Nat Chem Biol."},{"key":"241_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41594-018-0031-y","volume":"25","author":"J Yoo","year":"2018","unstructured":"Yoo J, et al. GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation. Nat Struct Mol Biol. 2018;25:217\u201324.","journal-title":"Nat Struct Mol Biol."},{"key":"241_CR51","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.cell.2018.10.037","volume":"175","author":"YY Dong","year":"2018","unstructured":"Dong YY, et al. Structures of DPAGT1 explain glycosylation disease mechanisms and advance TB antibiotic design. Cell. 2018;175:1045\u20131058.","journal-title":"Cell."},{"key":"241_CR52","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/ja.2017.101","volume":"70","author":"NP Price","year":"2017","unstructured":"Price NP, et al. Modified tunicamycins with reduced eukaryotic toxicity that enhance the antibacterial activity of \u03b2-lactams. J Antibiot. 2017;70:1070\u20131077.","journal-title":"J Antibiot."},{"key":"241_CR53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1128\/mr.50.3.259-279.1986","volume":"50","author":"S Omura","year":"1986","unstructured":"Omura S. Philosophy of new drug discovery. Microbiol Rev. 1986;50:259\u201379.","journal-title":"Microbiol Rev."},{"key":"241_CR54","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1021\/jo00050a009","volume":"57","author":"M Ubukata","year":"1992","unstructured":"Ubukata M, et al. Structure elucidation of liposidomycins, a class of complex lipid nucleoside antibiotics. J Org Chem. 1992;57:6392\u2013403.","journal-title":"J Org Chem."},{"key":"241_CR55","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/09168451.2018.1451740","volume":"2","author":"M Ubukata","year":"2018","unstructured":"Ubukata M. The logic of biologically active small molecules: amazing ability of microorganisms. Biosci Biotechnol Biochem. 2018;82:1063\u201372.","journal-title":"Biosci Biotechnol Biochem"},{"key":"241_CR56","doi-asserted-by":"publisher","first-page":"103","DOI":"10.7164\/antibiotics.50.103","volume":"50","author":"M Muroi","year":"1997","unstructured":"Muroi M, Kimura K, Osada H, Inukai M, Takatsuki A. Liposidomycin B inhibits in vitro formation of polyprenyl (pyro)phosphate N-acetylglucosamine, an intermediate in glycoconjugate biosynthesis. J Antibiot. 1997;50:103\u20134.","journal-title":"J Antibiot"},{"key":"241_CR57","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1128\/AAC.40.7.1640","volume":"40","author":"PE Brandish","year":"1996","unstructured":"Brandish PE, et al. Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli. Antimicrob Agents Chemother. 1996;40:1640\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"241_CR58","doi-asserted-by":"publisher","first-page":"640","DOI":"10.7164\/antibiotics.51.640","volume":"51","author":"K Kimura","year":"1998","unstructured":"Kimura K, et al. New types of liposidomycins that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. I. Producing organism and medium components. J Antibiot. 1998;51:640\u20136.","journal-title":"J Antibiot."},{"key":"241_CR59","doi-asserted-by":"publisher","first-page":"647","DOI":"10.7164\/antibiotics.51.647","volume":"51","author":"K Kimura","year":"1998","unstructured":"Kimura K, et al. New types of liposidomycins that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. II. Isolation and structure elucidation. J Antibiot. 1998;51:647\u201354.","journal-title":"J Antibiot."},{"key":"241_CR60","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.7164\/antibiotics.51.1099","volume":"51","author":"K Kimura","year":"1998","unstructured":"Kimura K, et al. Selective inhibition of the bacterial peptidoglycan biosynthesis by the new types of liposidomycins. J Antibiot. 1998;51:1099\u2013104.","journal-title":"J Antibiot."},{"key":"241_CR61","unstructured":"Suzuki K. unpublished data."},{"key":"241_CR62","doi-asserted-by":"publisher","first-page":"281","DOI":"10.7164\/antibiotics.52.281","volume":"52","author":"Y Esumi","year":"1999","unstructured":"Esumi Y, et al. New types of liposidomycins produced by Streptomyces that inhibit bacterial peptidoglycan synthesis. Structure elucidation of fatty acid components by tandem mass spectrometry. J Antibiot. 1999;52:281\u20137.","journal-title":"J Antibiot."},{"key":"241_CR63","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1006\/abio.2000.4952","volume":"289","author":"BC Tsvetanova","year":"2001","unstructured":"Tsvetanova BC, Price NP. Liquid chromatography-electrospray mass spectrometry of tunicamycin-type antibiotics. Anal Biochem. 2001;289:147\u201356.","journal-title":"Anal Biochem."},{"key":"241_CR64","doi-asserted-by":"publisher","first-page":"552","DOI":"10.7164\/antibiotics.56.552","volume":"56","author":"S Kagami","year":"2003","unstructured":"Kagami S, Esumi Y, Nakakoshi M, Yoshihama M, Kimura K. Control of liposidomycin production through precursor-directed biosynthesis. J Antibiot. 2003;56:552\u20136.","journal-title":"J Antibiot"},{"key":"241_CR65","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ijmm.2019.05.004","volume":"309","author":"F Wiker","year":"2019","unstructured":"Wiker F, Hauck N, Grond S, Gust B. Caprazamycins: biosynthesis and structure activity relationship studies. Int J Med Microbiol. 2019;309:319\u2013324.","journal-title":"Int J Med Microbiol"},{"key":"241_CR66","first-page":"3","volume":"74","author":"M Pstragowski","year":"2017","unstructured":"Pstragowski M, Zbrzezna M, Bujalska-Zadrozny M. Advances in pharmacotherapy of tuberculosis. Acta Pol Pharm. 2017;74:3\u201311.","journal-title":"Acta Pol Pharm."},{"key":"241_CR67","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41429-019-0189-5","volume":"72","author":"K Kimura","year":"2019","unstructured":"Kimura K. Studies of novel bioprobes isolated from rare natural sources using mutant yeasts. J Antibiot. 2019;72:579\u201389.","journal-title":"J Antibiot."},{"key":"241_CR68","doi-asserted-by":"publisher","unstructured":"Igarashi M. New natural products to meet the antibiotic crisis: a personal journey. J Antibiot. 2019. https:\/\/doi.org\/10.1038\/s41429-019-0224-6.","DOI":"10.1038\/s41429-019-0224-6"},{"key":"241_CR69","doi-asserted-by":"publisher","unstructured":"Ishizaki Y, et al. Synthesis and biological activity of CPZEN-45, a novel anti-tuberculosis drug. J Antibiot. 2019. https:\/\/doi.org\/10.1038\/s41429-019-0225-5.","DOI":"10.1038\/s41429-019-0225-5"},{"key":"241_CR70","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ejmech.2019.01.071","volume":"171","author":"B Patel","year":"2019","unstructured":"Patel B, et al. Caprazamycins: promising lead structures acting on a novel antibacterial target MraY. Eur J Med Chem. 2019;171:462\u201374.","journal-title":"Eur J Med Chem."},{"key":"241_CR71","doi-asserted-by":"publisher","first-page":"12684","DOI":"10.1074\/jbc.M109.094490","volume":"285","author":"L Kaysser","year":"2010","unstructured":"Kaysser L, et al. A new arylsulfate sulfotransferase involved in liponucleoside antibiotic biosynthesis in streptomycetes. J Biol Chem. 2010;285:12684\u201394.","journal-title":"J Biol Chem."},{"key":"241_CR72","doi-asserted-by":"publisher","unstructured":"Fujita Y, et al. Muraminomicins, new lipo-nucleoside antibiotics from Streptosporangium sp. SANK 60501-structure elucidations of muraminomicins and supply of the core component for derivatization. J Antibiot. 2019. https:\/\/doi.org\/10.1038\/s41429-019-0215-7.","DOI":"10.1038\/s41429-019-0215-7"},{"key":"241_CR73","doi-asserted-by":"publisher","first-page":"30309","DOI":"10.1074\/jbc.M113.492173","volume":"288","author":"Y Ishizaki","year":"2013","unstructured":"Ishizaki Y, et al. Inhibition of the first step in synthesis of the mycobacterial cell wall core, catalyzed by the GlcNAc-1-phosphate transferase WecA, by the novel caprazamycin derivative CPZEN-45. J Biol Chem. 2013;288:30309\u201319.","journal-title":"J Biol Chem"},{"key":"241_CR74","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1021\/acs.orglett.7b03623","volume":"20","author":"K Yamamoto","year":"2018","unstructured":"Yamamoto K, Yakushiji F, Matsumaru T, Ichikawa S. Total synthesis of tunicamycin V. Org Lett. 2018;20:256\u20139.","journal-title":"Org Lett."},{"key":"241_CR75","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.bmc.2019.02.035","volume":"27","author":"K Yamamoto","year":"2019","unstructured":"Yamamoto K, Katsuyama A, Ichikawa S. Structural requirement of tunicamycin V for MraY inhibition. Bioorg Med Chem. 2019;27:1714\u20139.","journal-title":"Bioorg Med Chem."},{"key":"241_CR76","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.drudis.2018.05.020","volume":"23","author":"J Herling","year":"2018","unstructured":"Herling J, Dunevall E, Ek M, Br\u00e4nd\u00e9n G. Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis. Drug Discov Today. 2018;23:1426\u201335.","journal-title":"Drug Discov Today."},{"key":"241_CR77","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/anie.201411954","volume":"54","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, et al. Total synthesis of (-)-caprazamycin A. Angew Chem Int Ed Engl. 2015;54:3136\u20139.","journal-title":"Angew Chem Int Ed Engl."},{"key":"241_CR78","doi-asserted-by":"publisher","first-page":"8527","DOI":"10.1021\/jacs.9b02220","volume":"141","author":"H Nakamura","year":"2019","unstructured":"Nakamura H, et al. Total synthesis of caprazamycin A: practical and scalable synthesis of syn-\u03b2-hydroxyamino acids and introduction of a fatty acid side chain to 1,4-diazepanone. J Am Chem Soc. 2019;141:8527\u201340.","journal-title":"J Am Chem Soc."},{"key":"241_CR79","doi-asserted-by":"publisher","first-page":"14987","DOI":"10.1074\/jbc.M901258200","volume":"284","author":"L Kaysser","year":"2009","unstructured":"Kaysser L, et al. Identification and manipulation of the caprazamycin gene cluster lead to new simplified liponucleoside antibiotics and give insights into the biosynthetic pathway. J Biol Chem. 2009;284:14987\u201396.","journal-title":"J Biol Chem."},{"key":"241_CR80","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/cbic.200900637","volume":"11","author":"L Kaysser","year":"2010","unstructured":"Kaysser L, Siebenberg S, Kammerer B, Gust B. Analysis of the liposidomycin gene cluster leads to the identification of new caprazamycin derivatives. ChemBioChem. 2010;11:191\u20136.","journal-title":"ChemBioChem."},{"key":"241_CR81","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/cbic.200900665","volume":"11","author":"M Funabashi","year":"2010","unstructured":"Funabashi M, et al. The biosynthesis of liposidomycin-like A-90289 antibiotics featuring a new type of sulfotransferase. Chembiochem. 2010;11:184\u201390.","journal-title":"Chembiochem."},{"key":"241_CR82","doi-asserted-by":"publisher","first-page":"11607","DOI":"10.1002\/anie.201305546","volume":"52","author":"M Funabashi","year":"2013","unstructured":"Funabashi M, et al. Structure-based gene targeting discovery of sphaerimicin, a bacterial translocase I inhibitor. Angew Chem Int Ed Engl. 2013;52:11607\u201311.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7604","key":"241_CR83","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature17636","volume":"533","author":"Ben C. Chung","year":"2016","unstructured":"Chung BC, et al. Structural insights into inhibition on lipid I production in bacterial cell wall synthesis. Nature. 2016; 533. https:\/\/doi.org\/10.1038\/nature17636.","journal-title":"Nature"},{"issue":"14","key":"241_CR84","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1080\/07391102.2018.1526715","volume":"37","author":"Bala Divya Mallavarapu","year":"2018","unstructured":"Divya MB, Abdullah M, Saxena S, Guruprasad L. Inhibitor binding studies of Mycobacterium tuberculosis MraY (Rv2156c): insights from molecular modeling, docking and simulation studies. J Biomol Struct Dyn. 2018:1\u201333. https:\/\/doi.org\/10.1080\/07391102.2018.1526715.","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"241_CR85","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1016\/j.bmc.2014.07.035","volume":"22","author":"A Mihalyi","year":"2014","unstructured":"Mihalyi A, Jamshidi S, Slikas J, Bugg TD. Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B. Bioorg Med Chem. 2014;22:4566\u201371.","journal-title":"Bioorg Med Chem."},{"key":"241_CR86","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ab.2014.05.018","volume":"461","author":"S Siricilla","year":"2014","unstructured":"Siricilla S, Mitachi K, Skorupinska-Tudek K, Swiezewska E, Kurosu M. Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I. Anal Biochem. 2014;461:36\u201345.","journal-title":"Anal Biochem."},{"key":"241_CR87","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ab.2016.08.008","volume":"512","author":"K Mitachi","year":"2016","unstructured":"Mitachi K, et al. Fluorescence-based assay for polyprenyl phosphate-GlcNAc-1-phosphate transferase (WecA) and identification of novel antimycobacterial WecA inhibitors. Anal Biochem. 2016;512:78\u201390.","journal-title":"Anal Biochem."},{"key":"241_CR88","doi-asserted-by":"publisher","unstructured":"Yamamoto K, Ichikawa S. Tunicamycin: chemical synthesis and biosynthesis. J. Antibiot. 2019. https:\/\/doi.org\/10.1038\/s41429-019-0200-1.","DOI":"10.1038\/s41429-019-0200-1"},{"key":"241_CR89","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.2174\/0929867325666180330095154","volume":"25","author":"MJ Fer","year":"2018","unstructured":"Fer MJ, et al. Bacterial transferase MraY, a source of inspiration towards new antibiotics. Curr Med Chem. 2018;25:6013\u201329.","journal-title":"Curr Med Chem."},{"key":"241_CR90","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.tim.2014.10.007","volume":"23","author":"G Niu","year":"2015","unstructured":"Niu G, Tan H. Nucleoside antibiotics: biosynthesis, regulation, and biotechnology. Trends Microbiol. 2015;23:110\u20139.","journal-title":"Trends Microbiol."},{"key":"241_CR91","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11274-017-2233-6","volume":"33","author":"S Chen","year":"2017","unstructured":"Chen S, Kinney WA, Lanen SV. Nature\u2019s combinatorial biosynthesis and recently engineered production of nucleoside antibiotics in Streptomyces. World J Microbiol Biotechnol. 2017;33:66.","journal-title":"World J Microbiol Biotechnol."},{"key":"241_CR92","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/ja.2013.49","volume":"67","author":"CT Walsh","year":"2014","unstructured":"Walsh CT, Wencewicz TA. Prospects for new antibiotics: a molecule-centered perspective. J Antibiot. 2014;67:7\u201322.","journal-title":"J Antibiot."},{"key":"241_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10957-9","volume":"10","author":"EH Mashalidis","year":"2019","unstructured":"Mashalidis EH, et al. Chemical logic of MraY inhibition by antibacterial nucleoside natural products. Nat Commun. 2019;10:2917.","journal-title":"Nat Commun"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-019-0241-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-019-0241-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-019-0241-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:03:04Z","timestamp":1744178584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-019-0241-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":93,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["241"],"URL":"https:\/\/doi.org\/10.1038\/s41429-019-0241-5","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,4]]},"assertion":[{"value":"19 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}